Amgen Statistics
Share Statistics
Amgen has 537.71M
shares outstanding. The number of shares has increased by 0.14%
in one year.
Shares Outstanding | 537.71M |
Shares Change (YoY) | 0.14% |
Shares Change (QoQ) | -0.06% |
Owned by Institutions (%) | 77.64% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 5 |
FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 14.54M, so 2.71% of the outstanding
shares have been sold short.
Short Interest | 14.54M |
Short % of Shares Out | 2.71% |
Short % of Float | 2.71% |
Short Ratio (days to cover) | 3.87 |
Valuation Ratios
The PE ratio is 34.48 and the forward
PE ratio is 12.74.
Amgen's PEG ratio is
-0.87.
PE Ratio | 34.48 |
Forward PE | 12.74 |
PS Ratio | 4.22 |
Forward PS | 3.8 |
PB Ratio | 23.99 |
P/FCF Ratio | 13.57 |
PEG Ratio | -0.87 |
Financial Ratio History Enterprise Valuation
Amgen has an Enterprise Value (EV) of 189.13B.
EV / Sales | 5.66 |
EV / EBITDA | 14.16 |
EV / EBIT | 16.46 |
EV / FCF | 18.2 |
Financial Position
The company has a current ratio of 1.26,
with a Debt / Equity ratio of 10.23.
Current Ratio | 1.26 |
Quick Ratio | 0.95 |
Debt / Equity | 10.23 |
Debt / EBITDA | 4.5 |
Debt / FCF | 5.78 |
Interest Coverage | 2.3 |
Financial Efficiency
Return on Equity is 69.59% and Return on Invested Capital is 8.91%.
Return on Equity | 69.59% |
Return on Assets | 4.45% |
Return on Invested Capital | 8.91% |
Revenue Per Employee | $1,193,714.29 |
Profits Per Employee | $146,071.43 |
Employee Count | 28,000 |
Asset Turnover | 0.36 |
Inventory Turnover | 1.84 |
Taxes
Income Tax | 519M |
Effective Tax Rate | 11.26% |
Stock Price Statistics
The stock price has increased by -13.05% in the
last 52 weeks. The beta is 0.5, so Amgen's
price volatility has been higher than the market average.
Beta | 0.5 |
52-Week Price Change | -13.05% |
50-Day Moving Average | 298.52 |
200-Day Moving Average | 302.54 |
Relative Strength Index (RSI) | 38.46 |
Average Volume (20 Days) | 3,078,108 |
Income Statement
In the last 12 months, Amgen had revenue of 33.42B
and earned 4.09B
in profits. Earnings per share was 7.56.
Revenue | 33.42B |
Gross Profit | 20.57B |
Operating Income | 7.26B |
Net Income | 4.09B |
EBITDA | 13.36B |
EBIT | 7.76B |
Earnings Per Share (EPS) | 7.56 |
Full Income Statement Balance Sheet
The company has 11.97B in cash and 60.1B in
debt, giving a net cash position of -48.13B.
Cash & Cash Equivalents | 11.97B |
Total Debt | 60.1B |
Net Cash | -48.13B |
Retained Earnings | -27.59B |
Total Assets | 89.37B |
Working Capital | 3.92B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 11.49B
and capital expenditures -1.1B, giving a free cash flow of 10.39B.
Operating Cash Flow | 11.49B |
Capital Expenditures | -1.1B |
Free Cash Flow | 10.39B |
FCF Per Share | 19.21 |
Full Cash Flow Statement Margins
Gross margin is 61.53%, with operating and profit margins of 21.71% and 12.24%.
Gross Margin | 61.53% |
Operating Margin | 21.71% |
Pretax Margin | 13.79% |
Profit Margin | 12.24% |
EBITDA Margin | 39.96% |
EBIT Margin | 21.71% |
FCF Margin | 31.1% |
Dividends & Yields
AMGN pays an annual dividend of $11.51,
which amounts to a dividend yield of 3.36%.
Dividend Per Share | $11.51 |
Dividend Yield | 3.36% |
Dividend Growth (YoY) | 5.78% |
Payout Ratio | 104.92% |
Earnings Yield | 2.9% |
FCF Yield | 7.37% |
Dividend Details Analyst Forecast
The average price target for AMGN is $317.5,
which is 16.7% higher than the current price. The consensus rating is "Hold".
Price Target | $317.5 |
Price Target Difference | 16.7% |
Analyst Consensus | Hold |
Analyst Count | 19 |
Stock Forecasts Stock Splits
The last stock split was on Nov 22, 1999. It was a
forward
split with a ratio of 2:1.
Last Split Date | Nov 22, 1999 |
Split Type | forward |
Split Ratio | 2:1 |
Scores
Altman Z-Score | 1.41 |
Piotroski F-Score | 7 |